Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study

Author:

Chouraki Vincent123,Preis Sarah R.24,Yang Qiong24,Beiser Alexa14,Li Shuo24,Larson Martin G.24,Weinstein Galit5,Wang Thomas J.26,Gerszten Robert E.789,Vasan Ramachandran S.210,Seshadri Sudha12

Affiliation:

1. Department of Neurology Boston University School of Medicine Boston MA USA

2. The Framingham Heart Study Framingham MA USA

3. Lille University, Inserm, Lille University Hospital, Institut Pasteur de Lille U1167 ‐ RID‐AGE ‐ Risk factors and molecular determinants of aging‐related diseases, Labex Distalz Lille France

4. Department of Biostatistics Boston University School of Public Health Boston MA USA

5. School of Public Health University of Haifa Israel

6. Division of Cardiovascular Medicine Vanderbilt Heart & Vascular Institute Nashville TN USA

7. Cardiology Division, Department of Medicine, Massachusetts General Hospital Harvard Medical School Boston MA USA

8. Broad Institute of MIT and Harvard Cambridge MA USA

9. Cardiovascular Research Center, Massachusetts General Hospital Harvard Medical School Boston MA USA

10. Department of Medicine (Sections of Preventive Medicine and Cardiology) Boston University School of Medicine Boston MA USA

Funder

National Heart, Lung, and Blood Institute

National Institute of Neurological Disorders and Stroke

National Institute on Aging

National Institute of Diabetes and Digestive and Kidney Diseases

National Heart, Lung, and Blood Institute's Framingham Heart Study

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Reference56 articles.

1. 2015 Alzheimer's disease facts and figures

2. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

3. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study The Lancet;Villemagne VL;Neurology,2013

4. Developing novel blood‐based biomarkers for Alzheimer's disease

5. Twenty years of Alzheimer’s disease-causing mutations

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3